Its considered the safest choice for both adults and children, regardless of age, gender, ethnicity, or BMI
They need to know how you are feeling so they can adjust your dosing schedule if necessary
Doctors usually move patients to this dose after theyve adjusted to 2.5 mg, especially when weight management and tighter glucose control are the goals
Yes, the FDAs black box warning for medullary thyroid carcinoma and MEN 2 syndrome applies to the entire class of GLP-1 receptor agonists, which include liraglutide (Saxeda and Victoza), dulaglutide (Trulicity), semaglutide (Ozempic, Rybelsus, and Wegovy), and tirzepatide (Mounjaro and Zepbound)